A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer
Stopped early · Phase 2
Conditions studied: Prostate Cancer
In brief
RATIONALE: Androgens can stimulate the growth of prostate cancer cells. Drugs such as aminoglutethimide or ketoconazole may stop the adrenal glands from producing hormones. Combining hydrocortisone with either aminoglutethimide or ketoconazole may be an effective treatment for prostate cancer. PURPOSE: Phase II trial to study the effectiveness of combining hydrocortisone with either aminoglutethimide or ketoconazole in treating patients who have localized stage IV prostate cancer.
Key facts
- Study ID
- NCT00006371
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
- People needed
- 2
- Starts
- 2000-05-01
- Expected to finish
- 2001-12-01
- Last updated by the study team
- 2012-09-27
Who can join
Age: any. Sex: male. Healthy volunteers: not accepted.
Where it is running
- H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.